Quarterly and annual results disclosed under 8-K Item 2.02.
Marvell Technology, Inc. reported the fourth fiscal quarter ended January 31, 2026 results: revenue $2.219 billion, net income $396.1 million, EPS $0.46 per diluted share.
“Net revenue for the fourth quarter of fiscal 2026 was $2.219 billion, $19.0 million above the mid-point of the Company’s guidance provided on December 2 , 2025. GAAP net income for the fourth quarter of fiscal 2026 was $396.1 million, or $0.46 per diluted share.”
Grove Collaborative Holdings, Inc. reported the 12-month period ending December 31, 2026 results: revenue approximately $140 million to $150 million. Guidance initiated.
“2026 Financial Outlook : For the 12-month period ending December 31st, 2026, Grove is providing the following guidance: For full-year 2026, the Company expects net revenue to be approximately $140 million to $150 million and Adjusted EBITDA to be approximately breakeven.”
Grove Collaborative Holdings, Inc. reported the year ended December 31, 2025 results: revenue $173.7 million, net income $11.7 million.
“Full Year 2025 Financial Results Revenue totaled $173.7 million, landing within the Company’s previously announced revised full-year guidance. This represents a 14.6% year-over-year decline, primarily due to a decrease in DTC orders. Net Revenue per Order was flat year-over-year. Gross Margin was 53.7%, a slight decrease from 53.8% year-over-year, driven by the removal of certain customer fees and a non-recurring benefit in the prior-year period related to the sell-through of previously reserved inventory, mostly offset by optimized discounting and higher allowances from vendors. Operating Expenses totaled $104.6 million, representing a 20.7% year-over-year decline due to reduced depreciation and amortization, lower stock-based compensation, ongoing cost optimization initiatives, and lower fulfillment costs. Net Loss was $11.7 million improving by $15.7 million year-over-year.”
Grove Collaborative Holdings, Inc. reported the quarter ended December 31, 2025 results: revenue $42.4 million, net income $1.6 million.
“Total Revenue was $42.4 million, down 14.3% year-over-year ● Adjusted EBITDA was $1.6 million, compared to a loss of $1.6 million in the prior-year period ● Net Loss was $1.6 million, compared to Net Loss of $12.6 million in the prior-year period”
FLYEXCLUSIVE INC. reported financial results for the full year ended December 31, 2025.
“On March 5, 2026, flyExclusive, Inc. (the “Company”) issued a corporate presentation of its financial results for the fourth quarter and full year ended December 31, 2025.”
FLYEXCLUSIVE INC. reported financial results for the fourth quarter ended December 31, 2025.
“On March 5, 2026, flyExclusive, Inc. (the “Company”) issued a corporate presentation of its financial results for the fourth quarter and full year ended December 31, 2025.”
Greenidge Generation Holdings Inc. reported the fourth quarter and fiscal year ended December 31, 2025 results: revenue Total revenue of $11.5 million, net income Net income of $1.9 to $2.9 million.
“million in potential future earnouts; and • Held 74 Bitcoin valued at $6.5 million as of December 31, 2025. Fourth Quarter 2025 Preliminary Financial Results: • Total revenue of $11.5 million, a reduction of $3.7 million from Q3 2025; • Net income of $1.9 to $2.9 million, a reduction of $10.1 to $9.1 million from Q3 2025; • EBITDA of $4.5 to $5.5 million, a reduction”
NewLake Capital Partners, Inc. reported the fourth quarter and year ended December 31, 2025 results: revenue $12.3 Million, net income $6.0 Million.
“Partners Reports Fourth Quarter and Full-Year 2025 Financial Results; Declared First Quarter 2026 Common Stock Dividend of $0.43 per Share Fourth Quarter 2025 Revenue totaled $12.3 Million Full Year 2025 Revenue totaled $51.1 Million Fourth Quarter 2025 Net Income Attributable to Common Stockholders totaled $6.0 Million, Funds From Operations totaled $10.0 Million,”
Contineum Therapeutics, Inc. reported the fourth quarter ended December 31, 2025 results: net income Net loss was $15.2 million for the three months ended December 31, 2025.
“On March 5, 2026, Contineum Therapeutics, Inc. (the “Company”) issued a press release announcing the Company’s financial results for the fourth quarter ended December 31, 2025.”
Victoria's Secret & Co. updated its fiscal year 2026 guidance (initiated).
“The Company is forecasting fiscal year 2026 net sales to be in the range of $6.850 billion to $6.950 billion compared to net sales of $6.553 billion in fiscal year 2025.”
Victoria's Secret & Co. updated its first quarter of 2026 guidance (initiated).
“The Company is forecasting net sales for the first quarter of 2026 to be in the range of $1.490 billion to $1.525 billion compared to net sales of $1.353 billion for the first quarter of 2025.”
Victoria's Secret & Co. reported full fiscal year ended January 31, 2026 results: revenue $6.553 billion, net income $161 million, or $1.93 per diluted share, EPS $1.93 per diluted share.
“The Company reported net sales of $6.553 billion for fiscal year 2025, an increase of 5% compared to net sales of $6.230 billion for fiscal year 2024 and above our previously communicated guidance range of $6.450 billion to $6.480 billion.”
Victoria's Secret & Co. reported the fourth quarter and fiscal year ended January 31, 2026 results: revenue $2.270 billion, net income $184 million, or $2.14 per diluted share, EPS $2.14 per diluted share.
“The Company reported net sales of $2.270 billion for the fourth quarter of 2025, an increase of 8% compared to net sales of $2.106 billion for the fourth quarter of 2024 and above our previously communicated guidance range of $2.170 billion to $2.200 billion.”
A.K.A. BRANDS HOLDING CORP. reported financial results for the fourth quarter and full year ended December 31, 2025.
“On March 5, 2026, a.k.a. Brands Holding Corp. (the "Company") issued a press release announcing its financial results for the fiscal quarter and year ended December 31, 2025.”
Brilliant Earth Group, Inc. reported the three and twelve months ended December 31, 2025 results: revenue $124.4 million and $437.5 million in the fourth quarter and fiscal year, respectively, net income GAAP Net loss of $1.3 million for the fourth quarter and net loss of $6.4 million for the fiscal year.
“three and twelve months ended December 31, 2025. Fourth Quarter and Fiscal Year 2025 Highlights (quarterly and annual periods ended December 31, 2025): • Delivered Net Sales of $124.4 million and $437.5 million in the fourth quarter and fiscal year, respectively. ◦ Largest quarter ever of Net Sales ◦ Total orders grew year-over-year 7% in Q4 and 13% in 2025 ◦ Repeat”
ArriVent BioPharma, Inc. reported the year ended December 31, 2025 results: net income Net loss was $166.3 million.
“ArriVent BioPharma, Inc. (the “Company”) issued a press release announcing its financial results for the fourth quarter and full year ended December 31, 2025.”
BridgeBio Oncology Therapeutics, Inc. reported financial results for the fourth quarter and full year ended December 31, 2025.
“BridgeBio Oncology Therapeutics, Inc. (“BBOT”) (Nasdaq: BBOT), a clinical-stage biopharmaceutical company focused on RAS-pathway malignancies, today reported financial results for the fourth quarter and full year ended December 31, 2025, and provided a business update”
Orion Properties Inc. reported full year ended December 31, 2025 results: revenue $147.6 million, net income $(139.3) million, or $(2.48) per share, EPS $(2.48) per share.
“Total revenues of $147.6 million • Net loss attributable to common stockholders of $(139.3) million, or $(2.48) per share”
Orion Properties Inc. reported fourth quarter ended December 31, 2025 results: revenue $35.2 million, net income $(35.8) million, or $(0.64) per share, EPS $(0.64) per share.
“Total revenues of $35.2 million • Net loss attributable to common stockholders of $(35.8) million, or $(0.64) per share”
Castellum, Inc. reported year ended December 31, 2025 results: revenue $52.9 million, net income $2.5 million.
“company focused on the federal government, announces certain unaudited highlights of its operating results for its year ended December 31, 2025. Revenue for 2025 increased to $52.9 million, representing an $8.1 million (15.2%) increase over $44.8 million in 2024. Operating loss improved to $2.8 million, a $4.4 million year-over-year improvement from an operating”
Drilling Tools International Corp reported 2026 results: revenue $155 million — $170 million. Guidance initiated.
“2026 Full Year Outlook Revenue $155 million — $170 million Adjusted EBITDA(1) $35 million — $45 million Adjusted EBITDA Margin(1) 23% — 26% Adjusted Free Cash Flow(1)(2) $17 million — $22 million”
Drilling Tools International Corp reported the twelve months of 2025 results: revenue $159.6 million, net income loss of approximately $3.8 million, EPS loss of $0.11 per share.
“For the twelve months of 2025, DTI generated total consolidated revenue of $159.6 million. 2025 Tool Rental revenue was $129.6 million and Product Sale revenue totaled approximately $30.1 million. Net Loss attributable to shareholders for 2025 was a loss of approximately $3.8 million or a loss of $0.11 per share.”
Drilling Tools International Corp reported the fourth quarter of 2025 results: revenue $38.5 million, net income $1.2 million, EPS $0.03 per share.
“For the fourth quarter of 2025, DTI generated total consolidated revenue of $38.5 million. Fourth quarter Tool Rental revenue was $30.4 million, and Product Sales revenue totaled approximately $8.1 million. Net Income attributable to common stockholders for the fourth quarter was $1.2 million or $0.03 per share.”
Granite Ridge Resources, Inc. reported the fourth quarter 2025 results: net income net loss of $25.1 million, EPS $(0.19) per share. Guidance initiated.
“Granite Ridge Resources, Inc. (NYSE: GRNT) (“Granite Ridge” or the “Company”) today reported financial and operating results for the fourth quarter and full-year 2025 and provided initial guidance for 2026. Fourth Quarter 2025 Highlights • Increased total production by 27% to 35,120 Boe/day (49% oil) including a 17% increase in oil production • Reported net loss of $25.1 million, or $(0.19) per share, and Adjusted Net Income (non-GAAP) of $1.5 million, or $0.01 Adjusted Earnings Per Diluted Share (non-GAAP) • Generated Adjusted EBITDAX (non-GAAP) of $69.5 million • Invested $127.5 million of capital, placing online 67 gross (10.50 net) wells • Declared a dividend of $0.11 per share • Ended the year with total liquidity of $339.5 million and Net Debt to Adjusted EBITDAX of 1.2x”
Bridger Aerospace Group Holdings, Inc. updated its 2026 guidance (initiated).
“Initiating 2026 guidance: Revenue expected to be between $135 million and $145 million”
Bridger Aerospace Group Holdings, Inc. reported the year ended December 31, 2025 results: revenue $122.8 million, net income $4.1 million.
“reported financial results for the fourth quarter and year ended December 31, 2025, including positive net income for the full year. Highlights: Revenue for 2025 grew 25% to $122.8 million, surpassing the company’s increased guidance range Positive Net Income for 2025 was $4.1 million, with adjusted EBITDA increasing 21% from 2024 to $45.3 million Completed $331.5”
Bridger Aerospace Group Holdings, Inc. reported the fourth quarter ended December 31, 2025 results: revenue $8.5 million, net income $15.1 million, EPS ($0.40) per diluted share.
“and advance our mission to protect lives, property, critical infrastructure, and the environment.” Fourth Quarter 2025 Results Revenue for the fourth quarter of 2025 was $8.5 million compared to $15.6 million in the fourth quarter of 2024. Excluding $0.8 million of revenue for return to service work performed on the four Spanish Super Scoopers as part of our”
Seaport Entertainment Group Inc. reported financial results for the quarter and year ended December 31, 2025.
“On March 4, 2026, Seaport Entertainment Group Inc. (the “Company” or “we”) issued an earnings press release relating to the Company’s financial results for the year ended December 31, 2025, and issued a related supplemental disclosure package.”
Evommune, Inc. reported fourth quarter and full year ended December 31, 2025 results: revenue Revenue was $0 million and $13.0 million for the fourth quarter and full year ended December 31, 2025, respectively, net income Net loss totaled $28.3 million and $68.9.
“Evommune, Inc. (the “Company”) issued a press release providing a business update and announcing its financial results for the three months and full year ended December 31, 2025”
ContextLogic Holdings Inc. reported the fourth quarter and fiscal year ended December 31, 2025 results: net income $13 million.
“Net loss was $13 million, compared to a net loss of $2 million in the fourth quarter of fiscal year 2024.”
KINGSTONE COMPANIES, INC. reported the year ended December 31, 2025 results: revenue $187,127, net income $40,767, EPS $2.88. Guidance initiated.
“Net premiums earned $ 49,463 $ 35,967 37.5% $ 187,127 $ 128,498 45.6% Direct premiums written 1 $ 82,753 $ 72,533 14.1% $ 277,801 $ 241,980 14.8% Net combined ratio 64.2% 78.5% (14.3)pts 75.0% 80.0% (5.0)pts Underlying combined ratio 1 62.6% 78.9% (16.3)pts 74.4% 79.5% (5.1)pts Net income $ 14,760 $ 5,439 171.4% $ 40,767 $ 18,358 122.1% Net income per share - diluted $ 1.03 $ 0.40 157.5% $ 2.88 $ 1.48 94.6%”
KINGSTONE COMPANIES, INC. reported the fourth quarter ended December 31, 2025 results: revenue $49,463, net income $14,760, EPS $1.03. Guidance initiated.
“Net premiums earned $ 49,463 $ 35,967 37.5% $ 187,127 $ 128,498 45.6% Direct premiums written 1 $ 82,753 $ 72,533 14.1% $ 277,801 $ 241,980 14.8% Net combined ratio 64.2% 78.5% (14.3)pts 75.0% 80.0% (5.0)pts Underlying combined ratio 1 62.6% 78.9% (16.3)pts 74.4% 79.5% (5.1)pts Net income $ 14,760 $ 5,439 171.4% $ 40,767 $ 18,358 122.1% Net income per share - diluted $ 1.03 $ 0.40 157.5% $ 2.88 $ 1.48 94.6%”
GAP INC reported fiscal year ended January 31, 2026 results: revenue $15.4 billion, net income $816 million, EPS $2.13.
“Net sales of $15.4 billion were up 2% compared to last year.”
GAP INC reported fourth quarter ended January 31, 2026 results: revenue $4.2 billion, net income $171 million, EPS $0.45.
“Net sales of $4.2 billion were up 2% compared to last year.”
KROGER CO updated its 2026 guidance (initiated).
“Kroger Reports Fourth Quarter and Full-Year 2025 Results and Announces Guidance for 2026”
KROGER CO reported fiscal year 2025 results: revenue Total company sales were $147.6 billion in 2025 compared to $147.1 billion in 2024, EPS Earnings Per Share (2) $1.54 $3.67.
“On March 5, 2026, The Kroger Co. (NYSE:KR) issued a press release announcing its fourth quarter and full year 2025 results.”
KROGER CO reported fourth quarter 2025 results: revenue Total company sales were $34.7 billion in the fourth quarter compared to $34.3 billion for the same period last year., EPS Earnings Per Share $1.35.
“Act. (2) Without rent, depreciation and amortization, fuel and adjustment items, if applicable. (3) Without fuel and adjustment items, if applicable. Total company sales were $34.7 billion in the fourth quarter compared to $34.3 billion for the same period last year. Excluding fuel, sales increased 2.1% compared to the same period last year. Gross margin was 23.1%”
METHODE ELECTRONICS INC reported third quarter of fiscal 2026 ended January 31, 2026 results: revenue $233.7 million, net income Net loss was $15.9 million, EPS $0.45 per diluted share. Guidance lowered.
“--- EX-99.1 Exhibit 99.1 Methode Electronics, Inc. Reports Fiscal 2026 Third Quarter Financial Results Progress on transformation amid mixed market conditions • Net sales of $233.7 million, down 2.6% year-over-year • Net loss of $15.9 million or 6.8% of net sales; adjusted EBITDA margin of 3.1% • Narrowed FY26 Sales guidance, lowered adjusted EBITDA guidance to $58”
MYERS INDUSTRIES INC reported the full year ended December 31, 2025 results: revenue $825,742, net income $34,928, EPS $0.93.
“Year Ended December 31, (Dollars in thousands, except per share data) 2025 2024 % Inc (Dec) Net sales $ 825,742 $ 836,281 (1.3 )% Gross profit $ 276,054 $ 270,805 1.9 % Gross margin 33.4 % 32.4 % Operating income $ 74,556 $ 44,480 67.6 % Net income $ 34,928 $ 7,201 385.0 % Net income per diluted share $ 0.93 $ 0.19 389.5 %”
MYERS INDUSTRIES INC reported the fourth quarter ended December 31, 2025 results: revenue $203,974, net income $11,330, EPS $0.30.
“Quarter Ended December 31, (Dollars in thousands, except per share data) 2025 2024 % Inc (Dec) Net sales $ 203,974 $ 203,876 0.0 % Gross profit $ 67,744 $ 65,889 2.8 % Gross margin 33.2 % 32.3 % Operating income $ 20,238 $ 14,637 38.3 % Net income $ 11,330 $ 4,297 163.7 % Net income per diluted share $ 0.30 $ 0.11 172.7 %”
Distribution Solutions Group, Inc. reported the twelve months ended December 31, 2025 results: revenue $1.98 billion, net income $8.3 million, EPS $0.18.
“2025 Full Year Summary (1) • Revenue was $1.98 billion, an increase of $175.9 million or 9.8% on one fewer selling day, of which $121.5 million resulted from five acquisitions only partially included in 2024. Organic average daily sales increased 3.6% for 2025 versus 2024. • Operating income increased $22.3 million from the prior year to $78.3 million, net of acquired intangible amortization of $46.5 million and $16.1 million of non-recurring severance and acquisition-related retention costs, stock-based compensation, acquisition-related costs and other non-recurring items. Adjusted operating income, excluding these non-cash and non-recurring items, decreased $7.5 million to $140.8 million compared to $148.4 million in 2024. • Net income increased by $15.7 million to $8.3 million in 2025 compared to a net loss of $7.3 million in the prior year. • Adjusted EBITDA was $175.2 million in 2025, or 8.9% of revenue, compared to $175.3 million or 9.7% of revenue in the prior year. Excluding th”
Distribution Solutions Group, Inc. reported the fourth quarter ended December 31, 2025 results: revenue $481.6 million, net income $(6.4 million).
“2025 Fourth Quarter Summary (2) • Revenue increased $1.1 million to $481.6 million, driven by $1.7 million of incremental revenue from two acquisitions closed in the fourth quarter of 2024, not included in the full fourth quarter of 2024. Organic average daily sales were flat compared to the year ago quarter. • Operating income was $7.7 million, net of $11.6 million of non-cash acquired intangible amortization and $7.2 million of non-recurring severance and acquisition-related retention costs, stock-based compensation, acquisition-related costs and other non-recurring items. This compares to an operating income of $20.1 million in the prior year quarter. Adjusted operating income, excluding these non-cash and non-recurring items, was $26.5 million in the current quarter compared to $37.3 million in the year-ago quarter. • Net loss was $6.4 million for the quarter compared to net loss of $25.9 million in the prior year quarter which was negatively impacted by”
COOPER COMPANIES, INC. reported fiscal first quarter ended January 31, 2026 results: revenue $1.024 billion, EPS $0.66. Guidance raised.
“(Nasdaq: COO), a leading global medical device company, today announced financial results for its fiscal first quarter ended January 31, 2026. • First quarter 2026 revenue of $1.024 billion, up 6%, or up 3% organically, from last year's first quarter. • First quarter 2026 GAAP diluted earnings per share (EPS) of $0.66, up $0.14 or 27% from last year's first quarter.”
ONE LIBERTY PROPERTIES INC reported financial results for the quarter and year ended December 31, 2025.
“On March 5, 2026, we issued a press release announcing our results of operations for the quarter and year ended December 31, 2025.”
TORO CO reported financial results for three month period ended January 30, 2026.
“On March 5, 2026, The Toro Company announced its financial results for the three month period ended January 30, 2026.”
RAND CAPITAL CORP reported the full year ended December 31, 2025 results: revenue $6.5 million, EPS $1.80 per share.
“and no debt outstanding , providing substantial balance sheet flexibility for future investments ● Total investment income was $1.3 million for the fourth quarter and $6.5 million for full year 2025, reflecting the impact of portfolio repayments and pace of deal origination ● Net asset value (NAV) per share was $17.57 at December 31, 2025 ● Received”
RAND CAPITAL CORP reported the fourth quarter ended December 31, 2025 results: revenue $1.3 million, EPS $0.20 per share.
“with more than $23 million in total liquidity and no debt outstanding , providing substantial balance sheet flexibility for future investments ● Total investment income was $1.3 million for the fourth quarter and $6.5 million for full year 2025, reflecting the impact of portfolio repayments and pace of deal origination ● Net asset value (NAV) per share was”
Inuvo, Inc. reported the fiscal year ended December 31, 2025 results: revenue $86.2 million, net income Net loss for the full year ended December 31, 2025, totaled $5.1 million, EPS $0.35 per basic and diluted share.
“for the same period in 2024, driven by the aforementioned strategic Platform reset, which primarily impacted the fourth quarter. Net revenue for the full year 2025 increased to $86.2 million from $83.8 million in 2024, reflecting growth in the first nine months of the year from both Platform and Agencies and Brands. Full year revenue was impacted by the fourth”
Inuvo, Inc. reported the fourth quarter ended December 31, 2025 results: revenue $14.3 million, net income Net loss for the fourth quarter of 2025 was $0.6 million, EPS $0.04 per basic and diluted share.
“intelligent, privacy-forward solutions that deliver outsized returns.” Financial Results for the Fourth Quarter and Full Year 2025 Net revenue for the fourth quarter of 2025 was $14.3 million, down from $26.2 million for the same period in 2024, driven by the aforementioned strategic Platform reset, which primarily impacted the fourth quarter. Net revenue for the full”
Lineage Cell Therapeutics, Inc. reported financial results for quarter and year ended December 31, 2025.
“On March 5, 2026, Lineage Cell Therapeutics, Inc. issued a press release announcing financial results for the quarter and year ended December 31, 2025”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.